Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.

Background: There is concern about the potential of an increased risk related to medications that act on the renin-angiotensin-aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), because the viral receptor is angiotensin-converting enzyme 2 (ACE2).Methods: We assessed the...

Descripción completa

Detalles Bibliográficos

Publicado en:	New England Journal of Medicine Vol. 382; no. 25; pp. 2441 - 2449
Autores principales:	Reynolds, Harmony R., Adhikari, Samrachana, Pulgarin, Claudia, Troxel, Andrea B., Iturrate, Eduardo, Johnson, Stephen B., Hausvater, Anai's, Newman, Jonathan D., Berger, Jeffrey S., Bangalore, Sripal, Katz, Stuart D., Fishman, Glenn I., Kunichoff, Dennis, Yu Chen, Ogedegbe, Gbenga, Hochman, Judith S., Hausvater, Anaïs, Chen, Yu
Formato:	Journal Article
Publicado:	New England Journal of Medicine 7/18/2020
Acceso en línea:	Ver este registro en EBSCOhost